Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Nirrin Technologies, Inc.

Nirrin Technologies, Inc.

Stage unknownBillerica, MABiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
2 rounds
  1. Sep 23, 2025
    Form D equity offering · $6.7M (form d sold) · 23 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Nirrin Technologies, Inc. filed Form D: $6,699,781 sold of $9,711,196, Biotechnology”
  2. Feb 1, 2024
    Form D equity offering · $4.8M (form d sold) · 20 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Nirrin Technologies, Inc. filed Form D: $4,818,026 sold of $6,000,000, Biotechnology”
Investors on record
1 edges
People
3 officers, 7 directors
Timeline
2
  1. Jun 15, 2026
    Nirrin Technologies, Inc. filed Form D: $6,699,781 sold of $9,711,196, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Feb 14, 2024
    Nirrin Technologies, Inc. filed Form D: $4,818,026 sold of $6,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
28 observations
Every observation on this company